Author:
Fouquet G.,Franchi P.,Mittaine-Marzac B.,Laporte N.,Ihaddadene H.,Decroocq J.,Breal C.,Bouscary D.,Ammar F.,Zogo A.,Burgun S.,Zerbit J.,Willems L.,Deau-Fischer B.,Vignon M.
Publisher
Springer Science and Business Media LLC
Reference9 articles.
1. Burki TK (2020) Cancer guidelines during the COVID-19 pandemic. Lancet Oncol 21:629–630
2. Karacin C, Acar R, Bal O, et al. ‘Swords and Shields’ against COVID-19 for patients with cancer at ‘clean’ and ‘pandemic’ hospitals: are we ready for the second wave? Support Care Cancer. Epub ahead of print 22 January 2021. https://doi.org/10.1007/s00520-021-06001-6
3. Terpos E, Engelhardt M, Cook G et al (2020) Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN). Leukemia 34:2000–2011
4. Infection au nouveau Coronavirus (SARS-CoV-2), COVID-19, France et Monde, /maladies-et-traumatismes/maladies-et-infections-respiratoires/infection-a-coronavirus/articles/infection-au-nouveau-coronavirus-sars-cov-2-covid-19-france-et-monde (accessed 22 April 2020)
5. Touati M, Lamarsalle L, Moreau S et al (2016) Cost savings of home bortezomib injection in patients with multiple myeloma treated by a combination care in Outpatient Hospital and Hospital care at Home. Support Care Cancer 24:5007–5014
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献